Understanding the Impact of Authorized Generics on Drug Pricing: The Entacapone Case Study
DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence - A podcast by DrugPatentWatch
Categories:
In the world of prescription drugs, brand-name manufacturers have employed various strategies to maintain revenue streams in the face of generic competition. One such strategy is the use of “authorized generics” (AGs) – essentially the same drug sold under a generic name, often at a slightly discounted price. This tactic came into the spotlight in […] Source